Showa Pharmaceutical University · Laboratory of Pharmaceutics

Research keywordsadenovirus vectors・dendritic cell immunotherapy・tumor vasculature targeting・cancer vaccines・mucosal vaccine adjuvants・TNFR1-selective TNF mutants・cell-penetrating peptides

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• The infectivity of progeny adenovirus in the presence of neutralizing antibody Hirai T, Sato A, Koizumi N, Kuriouka Y, Suzuki Y, Kano J, Yamakawa M, Nomura T, Fujii M, Sakurai F, Mizuguchi H, Watanabe Y, Utoguchi N J Gen Virol 102(4) 1-11 20212021
• Fiber-knob region of Adenovirus type 5 vector promotes migration of A549 cells Kano J, Koizumi N, Terada A, Matsuoka A, Hirai T, Nomura T, Mizuguchi H, Utoguchi N BPB Reports 4(1) 17-21 20212021
• Adenovirus fiber can distribute itself to the cell surface without membrane damage Satoh A, Hirai T, Koizumi N, Hatakeyama S, Watanabe A, Nomura T, Sakurai F, Mizuguchi H, Utoguchi N BPB Reports 2(6) 113-118 20192019
• 免疫逃避機構の克服を目指した2型受容体選択的TNFアンタゴニストの創製 野村 鉄也 Medical science digest 45(2) 24-25 20192019

• Official profile